CVS Health stock (NYSE: CVS) has emerged as one of the top performers this year, appreciating nearly 50%, significantly outpacing the broader S&P500 index which has declined 4%. Investors appear optimistic that the company may overcome its challenges following last year’s 40% stock price decline, which was primarily driven by rising medical costs impacting profitability….
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Updated: State Farm, Consumer Group Battle Ahead of Commish Decision
3 High-Yield Dividend Stocks to Buy Before March Ends
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News